PETX - Aratana Therapeutics misses by $0.03 beats on revenue May, 08 2019 04:21 PM Aratana Therapeutics Inc. Aratana Therapeutics (NASDAQ:PETX): Q1 GAAP EPS of -$0.14 misses by $0.03.Revenue of $7.4M (+83.2% Y/Y) beats by $0.6M.Press ReleaseMore news on: Aratana Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,